As artificial intelligence tools become more embedded in clinical and administrative workflows, a new legal question is emerging for healthcare organizations: Could AI chat histories be used as evidence in medical malpractice litigation?
Recent federal court decisions suggest the answer is evolving—and uncertain. For providers, that uncertainty creates real exposure.
A developing legal landscape
Courts are beginning to recognize interactions with generative AI platforms as potential records subject to discovery. While this issue is still taking shape, two recent federal rulings—issued on the same day in February 2026—underscore how inconsistent the legal treatment can be.
In one case, a court found that AI-assisted work tied to litigation preparation was protected. In another, a court allowed AI-generated conversations to be used as evidence.
The takeaway is not the specific outcomes, but the broader signal: AI chat histories are no longer invisible in the eyes of the law.
Why this matters in medical malpractice
Healthcare professionals are increasingly using AI tools to support their work. Common use cases include:
- Drafting or refining clinical documentation
- Exploring possible diagnoses or treatment options
- Summarizing patient histories
- Researching medical guidelines
- Preparing responses to patient complaints or adverse events
While these uses may improve efficiency, they also generate a record—one that may later be requested in litigation.
In a malpractice case, such records could be interpreted as evidence of:
- Clinical reasoning and decision-making
- Awareness of potential diagnoses
- Consideration (or omission) of alternative treatments
- Knowledge of risks or standards of care
Even informal or exploratory prompts could be scrutinized by opposing counsel.
The confidentiality misconception
One of the most significant risks is the assumption that AI interactions are private.
In reality, courts may treat these tools as third-party platforms rather than internal systems. That distinction has legal consequences. Communications with AI tools may not be protected in the same way as internal notes or privileged discussions.
In at least one ruling, a court emphasized that AI platforms are not licensed professionals, and user interactions may be stored or shared according to platform terms. This weakens arguments that such communications are confidential.
For clinicians, this creates a gap between perception and legal reality.
Practical steps for healthcare organizations
AI is not going away—and it doesn’t need to. But its use in clinical environments requires clearer guardrails.
Define appropriate use cases
Establish boundaries around when AI can and cannot be used, particularly for patient-specific decision-making, diagnostic reasoning, or adverse event analysis.
Educate clinical and administrative staff
Training should emphasize that AI prompts and outputs may be retained and disclosed, and could later appear in litigation.
Strengthen policies and compliance oversight
Review AI usage policies alongside HIPAA and data governance requirements. Clearly define what information may be entered into AI systems and which platforms are approved.
Plan for discovery and record retention
Assume that AI-generated content may be treated similarly to other business or clinical records in legal proceedings.
Prepare for legal variability
As recent rulings show, courts are not aligned. Outcomes may depend heavily on context, intent, and how the AI tool was used.
Looking ahead
AI is rapidly becoming part of everyday healthcare delivery. At the same time, it is becoming part of how care is examined in court.
For healthcare organizations, the shift is subtle but critical: AI interactions should be approached with the same level of caution as any other documentation that could be reviewed in a malpractice claim.
What feels like a private exchange with a digital assistant may ultimately be viewed as part of the evidentiary record.
Dr Brody will be lecturing on the topic of AI in the Podiatry Practice at the 110th Annual Ohio Foot and Ankle Scientific Seminar in Columbus Ohio later this month. For more information about that event visit : https://ohfama.org/aws/OHFAMA/pt/sp/conference_home_page
Read Comments